Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 364 across all filing types
Latest filing 2024-03-13 Capital/Financing Update
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Strategic Investment from Craig Sellars 2 pages 581.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 14 March 2024 regarding a strategic investment of AUD$1.0 million from Craig Sellars into Singular Health Group Ltd. It details the terms of the investment, the background of the investor, and includes quotes from the investor and the company's CEO. The document is an announcement of a capital raising event via a placement of new shares, including pricing and shareholder approval conditions. It does not contain financial statements, earnings data, or detailed management discussion. The document length is 4293 characters, which is relatively short and focused on the investment news. Therefore, this fits the category of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2024-03-13 English
Proposed issue of securities - SHG 5 pages 17.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed placement of 6,666,667 ordinary fully paid shares by Singular Health Group Ltd. It includes specifics such as the issue price, proposed issue date, shareholder approval requirements, and compliance with ASX Listing Rules. The content focuses on the announcement of a new share issue and capital raising activity. There are no financial statements or management discussion of results, so it is not an Annual Report or Interim Report. It is not a regulatory certification or voting result announcement. The document fits the category of a Capital/Financing Update as it announces a new securities issuance and placement details.
2024-03-13 English
Pause in Trading 1 page 119.4KB
Regulatory Filings Classification · 95% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It is very short (343 characters) and does not contain any financial data, report content, or detailed information. It is an announcement related to trading status, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-12 English
Trading Halt 2 pages 151.9KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from ASX Compliance regarding a trading halt requested by Singular Health Group Limited. The halt is pending an announcement related to a capital raising. The text explicitly states the halt is requested under ASX Listing Rule 17.1 and is awaiting a forthcoming announcement. There is no financial data, report content, or detailed analysis present. The document is short (1719 characters) and serves as a notification of a trading halt rather than a report or detailed filing. This fits the category of Capital/Financing Update (CAP) because it relates to a capital raising event and the trading halt is directly connected to that financing activity.
2024-03-12 English
Half Year Accounts 34 pages 1.7MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Report - 31 December 2023' and contains detailed financial and operational information for the half-year ended 31 December 2023. It includes a Directors' report, review of operations, corporate activities, regulatory updates, and product development details. The content is comprehensive and clearly pertains to a half-year financial period, which aligns with the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), indicating it is the report itself, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2024
2024-02-28 English
Appendix 4D 2 pages 336.1KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Singular Health Group Limited Appendix 4D Half-year report' and covers the half-year period ended 31 December 2023. It contains financial results including revenues, losses, net tangible assets, and details about control over entities and associates. The document also references the Directors' Report and Consolidated Interim Financial Report for the same period, indicating it is a summary or announcement of interim financial results. The length is 2779 characters, which is relatively short and consistent with an announcement rather than a full interim report. Appendix 4D is a regulatory form used in Australia for half-year financial reporting announcements. Given these factors, the document is best classified as an Interim / Quarterly Report (IR) because it provides substantive financial data for a half-year period, not just an announcement of a report publication or a certification. Therefore, the classification is IR with high confidence. H1 2024
2024-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.